Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Clinical Summary and Overview

To clearly understand the clinical aspects involved in Atopic Dermatitis This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Dermatite Atópica e o Contexto do Coronavírus: O Paciente é Grupo de Risco?

Uma dúvida frequente entre pais e cuidadores durante o período crítico da pandemia de COVID-19 envolvia a segurança de crianças com condições alérgicas crônicas. O caso de uma criança de dois anos com diagnóstico de dermatite atópica, caracterizada por lesões avermelhadas e descamativas pelo corpo, ilustra bem esse questionamento. A preocupação principal reside em saber se apenas a manifestação cutânea isolada colocaria o paciente no grupo de risco para formas mais graves da infecção pelo coronavírus.

Do ponto de vista clínico e imunológico, o paciente que apresenta exclusivamente a dermatite atópica, sem histórico de comprometimento respiratório associado, não é considerado pertencente ao grupo de risco para complicações graves da COVID-19. A dermatite atópica é uma doença inflamatória crônica da pele, de origem imunológica, que requer cuidados diários específicos, mas que não compromete a função pulmonar ou a resposta sistêmica ao vírus da mesma forma que as doenças respiratórias crônicas.

No entanto, a convivência com a dermatite atópica exige atenção redobrada quanto aos cuidados de higiene recomendados pelas autoridades de saúde:

  • Desafios com a higienização: O uso frequente de álcool a 70% para a desinfecção das mãos e superfícies pode ressecar intensamente a pele, desencadeando crises ou piorando o prurido e a vermelhidão em pacientes atópicos.
  • Escolha de produtos adequados: Recomenda-se a busca por formulações de álcool gel que possuam agentes hidratantes e protutores cutâneos em sua composição.
  • Isenção de fragrâncias: É fundamental que qualquer produto aplicado na pele da criança seja totalmente livre de perfumes, corantes e substâncias químicas irritantes que possam agravar o quadro dermatológico.

Vale ressaltar que o cenário muda caso o paciente com dermatite atópica desenvolva comorbidades respiratórias associadas, como a asma alérgica ou a rinossinusite crônica — condições frequentemente associadas à marcha atópica. Nesses casos, a presença de hiper-reatividade brônquica ou asma representa, de fato, um fator de risco relevante para complicações respiratórias decorrentes de infecções virais como o coronavírus.

Este conteúdo possui caráter exclusivamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a avaliação individualizada com um médico especialista em Alergia e Imunologia.

Developments in Evidence-Based Medicine: Cutaneous Immunopathology and Restoration of the Epithelial Barrier

Evidence-based medicine demonstrates that chronic inflammatory dermatoses involve the interaction between epidermal barrier dysfunction (such as mutations or reduced expression of the protein). filaggrin and ceramides in the stratum corneum in atopic dermatitis, facilitating transepidermal water loss and the penetration of aeroallergens and staphylococcal antigens) and polarized immune activation (predominance of Th2/Th22 with IL-4, IL-13 and IL-31 in atopic dermatitis; delayed-type IV hypersensitivity mediated by T lymphocytes in allergic contact eczema diagnosed by contact test / patch test; and the IL-23/Th17/TNF-α axis in psoriasis). Structured management combines intensive restorative hydration, inflammation control with topical corticosteroids or calcineurin inhibitors (proactive therapy), eradication of proven triggers, and, in aeroallergen-sensitized or severe cases, specific immunotherapy and targeted therapies.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Skin Barrier Health, Immune Inflammation, and Pruritus Control

Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization

The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.

Therapeutic Hydration, Skin Tests and Immunotherapy

The daily pillar of protection consists of immediate intensive hydration after quick, lukewarm showers with syndet cleansers (without alkaline soap), combined with personalized protocols of... tratamento de dermatite atópicaIn causal investigation, the allergy test (whether it's a prick test for aeroallergens or a patch test for chemicals) guides precise avoidance measures and enables the indication of allergy vaccine in patients sensitized to dust mites.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. For peaceful skin, free from constant itching and sleep-depriving flare-ups.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Atopic Dermatitis It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: